Torrent Pharma Inc. has recalled 73,896 bottles of Losartan Potassium and Losartan Potassium/Hydrochlorothiazide tablets, which are used to treat high blood pressure. Testing confirmed that certain lots of these medications contain an impurity called N-Methylnitrosobutyric acid (NMBA) at levels higher than the daily limit allowed by the FDA. Consumers should contact their doctor or pharmacist to discuss an alternative treatment before stopping the medication, as stopping blood pressure medicine abruptly can pose immediate health risks. These prescription-only medications were distributed across the United States and Puerto Rico in bottles of 90 or 1,000 tablets.
The impurity NMBA is a known environmental contaminant and is classified as a potential human carcinogen. While no immediate injuries have been reported, long-term exposure to this substance above acceptable levels may increase the risk of developing cancer.
Medication refund and healthcare consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.